[link removed]
[link removed] [link removed]
View web version ([link removed])
[link removed]
Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel
A coronavirus vaccine developed by Johnson & Johnson and Beth Israel Deaconess Medical Center will start undergoing testing on volunteers in a large study Wednesday, the fourth vaccine candidate to reach that milestone but the first that would offer protection from COVID-19 after one shot instead of two.

Read the full story. ([link removed])
Live tracker: Coronavirus vaccines to keep an eye on ([link removed])
------------------------------------------------------------
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list. ([link removed])
------------------------------------------------------------
[link removed]
[link removed] [link removed]

============================================================
** Like us ([link removed])
** Follow us ([link removed])
You received this message because you signed up for Breaking News Alerts.

Copyright © 2020 The Boston Globe, All rights reserved.

Our mailing address is:
The Boston Globe
1 Exchange Place Suite 201
Boston, MA 02109-2132
USA

** unsubscribe from this list ([link removed])

** Manage Your Account ([link removed])
| ** Terms of Service ([link removed])
| ** Privacy Policy ([link removed])
| ** Help Center ([link removed])
| ** Advertise (mailto:[email protected]?subject=Advertising+in+BostonGlobe.com)